Applicability of biomarkers in the early diagnosis of prostate cancer.
about
Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate CancerCancer diagnostic classifiers based on quantitative DNA methylationStructural and functional analysis of human prostatic acid phosphatase.Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platform.Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples.DNA methylation gene-based models indicating independent poor outcome in prostate cancer.Evaluation of phage display discovered peptides as ligands for prostate-specific membrane antigen (PSMA).Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer.Evidence of heavy methylation in the galectin 3 promoter in early stages of prostate adenocarcinoma: development and validation of a methylated marker for early diagnosis of prostate cancer.Ability of PITX2 methylation to predict survival in patients with prostate cancer.Transcriptome Identified lncRNAs Associated with Renal Fibrosis in UUO Rat Model.DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy.Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of prostate cancer in the Han population of China.Gene Expression Profile of Prostate Cancer Patients by Chemiluminescent AnalysisDNA methylation ofPITX2predicts poor survival in men with prostate cancer
P2860
Q26767044-25B68FBF-4C98-4271-A8E5-6B13209C58DDQ27012960-7FB8623B-E052-411B-821C-7CD3BC5F7F93Q30391641-CD6EF3C7-2865-44B9-B26E-2B665A8429E6Q33828430-2E0E21ED-3BC7-4321-A9E9-D6996CEC58F7Q34014559-C12CE390-5D69-4CB0-92CD-3843FCB7AB2EQ34174356-CDF5C96E-7073-407F-BB23-23FB1788D327Q34918072-17B191DC-F1E5-45B7-82A4-A625895DB067Q34957004-7E8286DD-9601-4DC5-AD6A-92FB87F8A3F8Q37313689-8919C914-338B-4988-89CA-C73179799DAFQ40230694-16FEC5C2-C540-49FC-A801-9FB08AB1F286Q41605973-C88C7342-9CF9-4FCB-8B6C-0145C07293D4Q42676794-4B4F5EBB-D687-42E5-B423-96DC00E08A60Q54351805-E7BBFE84-EADD-4CF0-A041-422B455FFDE8Q58129611-76D210C3-2E49-4278-9D8F-935F658145DAQ58327420-2CE32E8E-927A-4E5C-BA00-ADD710531955
P2860
Applicability of biomarkers in the early diagnosis of prostate cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Applicability of biomarkers in the early diagnosis of prostate cancer.
@ast
Applicability of biomarkers in the early diagnosis of prostate cancer.
@en
type
label
Applicability of biomarkers in the early diagnosis of prostate cancer.
@ast
Applicability of biomarkers in the early diagnosis of prostate cancer.
@en
prefLabel
Applicability of biomarkers in the early diagnosis of prostate cancer.
@ast
Applicability of biomarkers in the early diagnosis of prostate cancer.
@en
P2093
P2860
P356
P1476
Applicability of biomarkers in the early diagnosis of prostate cancer.
@en
P2093
Daphne Hessels
Gerald W Verhaegh
J Alfred Witjes
Jack A Schalken
P2860
P304
P356
10.1586/14737159.4.4.513
P577
2004-07-01T00:00:00Z